Blackstone buys Clarus to bulk up in life sciences

(Reuters) - Blackstone Group LP (BX.N) said on Thursday it has agreed to acquire life sciences investment firm Clarus, in an effort by the world’s largest alternative asset manager to scale up its investments in healthcare.